Washington SB 5292: Concerning prescription drug cost transparency.

Status: Senate Rules "X" file. (as of 2020-01-13)

State: Washington · Session: 2019-2020 · Bill: SB 5292

Subjects: FINANCIAL MANAGEMENT, OFFICE, DRUGS, PUBLIC FUNDS AND ACCOUNTS, INSURANCE

Sponsors: Keiser, Cleveland, Conway, Das, Hasegawa, Kuderer, Liias, Nguyen, Randall, Saldaña, Van De Wege, Wellman, Wilson, C.

View Washington SB 5292 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.